The FDA approved use of the Atalante X robotic exoskeleton, which allows people with mobility issues to stand upright, for MS rehabilitation.
Hosted on MSN
PoNS therapy shows promise for MS gait deficits
NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $3.84 million, announced significant findings from the PoNS Therapeutic Experience ...
The way you walk, something you likely perform automatically thousands of times daily, contains a wealth of information about your overall health. Gait analysis, once primarily the domain of elite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback